Revance Therapeutics Inc (NASDAQ: RVNC) has reported topline data from JUNIPER Phase 2 study evaluating DaxibotulinumtoxinA for Injection to treat adults with moderate to severe upper limb spasticity.

March 10, 2010 (UPDATED March 17, 2010) — The US Food and Drug Administration (FDA) has approved a new indication for onabotulinumtoxin A injection (Botox; Allergan, Inc) for upper limb spasticity.

Upper limb spasticity, or involuntary overactivity of muscles caused by upper motor neuron damage to the brain or spinal cord, is a common complication of stroke and is often associated with deformity ...

What Is Upper Limb Spasticity? Upper limb spasticity is a condition that affects the way you move your arms. It makes your muscles stiff and flexed. Sometimes, your arms will twitch or move in a way ...

Merz North America announced that Xeomin (incobotulinumtoxinA) has been approved by the Food and Drug Administration (FDA) for the treatment of upper limb spasticity in adults. Merz North America ...

— Achieved key co-primary endpoint on efficacy, with 500U dose demonstrating statistically significant difference from placebo in the Modified Ashworth Score (MAS) improvement from baseline — ...

Continuing our series on diagnoses that may be missed in a primary care setting, Dr Ahmed Mostafa describes a case of upper limb DVT that was initially misdiagnosed A 39-year-old female patient ...